default author photo

Rodolphe Thiébaut

University of Bordeaux - SISTM team, UMR 1219

SCHOLARLY PAPERS

5

DOWNLOADS

347

TOTAL CITATIONS

0

Scholarly Papers (5)

1.

Estimating the Population Effectiveness of Interventions Against COVID-19 in France: A Modelling Study

Number of pages: 22 Posted: 26 Jun 2023
University of Bordeaux - SISTM team, UMR 1219, McGill University - School of Population and Global Health, York University - Centre for Diseases Modeling (CDM), University of Bordeaux - SISTM team, UMR 1219 and University of Bordeaux - SISTM team, UMR 1219
Downloads 90 (747,755)

Abstract:

Loading...

COVID-19, SARS-CoV2, epidemics, dynamics, mathematical model, nonpharmaceutical interventions, vaccines

2.

The Benefit of Augmenting Open Data with Clinical Data-Warehouse EHR for Forecasting SARS-CoV-2 Hospitalizations in Bordeaux Area, France

Number of pages: 25 Posted: 31 Mar 2022
University of Bordeaux - SISTM team, UMR 1219, University of Bordeaux - CHU de Bordeaux, University of Bordeaux - CHU de Bordeaux, University of Bordeaux - ISPED, INSERM U1219, Inria BSO, University of Bordeaux - SISTM team, UMR 1219 and Independent
Downloads 74 (860,052)

Abstract:

Loading...

SARS-CoV-2, forecasting, electronic health records, Data Warehouse, machine learning

3.

Non-adjuvanted CD40-targeting SARS-CoV-2 Vaccines Induce Broad Long-lasting Protection in Non-human Primates

Number of pages: 48 Posted: 19 Sep 2025
University of Paris-Saclay - Center for Immunology of Viral, Auto-immune, Hematological and Bacterial Diseases (IMVA-HB/IDMIT), Université Paris Est Créteil, University of Paris-Saclay - Center for Immunology of Viral, Auto-immune, Hematological and Bacterial Diseases (IMVA-HB/IDMIT), University of Paris-Saclay - Center for Immunology of Viral, Auto-immune, Hematological and Bacterial Diseases (IMVA-HB/IDMIT), University of Bordeaux - ISPED, INSERM U1219, Inria BSO, University of Paris-Saclay - Center for Immunology of Viral, Auto-immune, Hematological and Bacterial Diseases (IMVA-HB/IDMIT), University of Paris-Saclay - Center for Immunology of Viral, Auto-immune, Hematological and Bacterial Diseases (IMVA-HB/IDMIT), Université Paris Est Créteil, University of Lausanne - Service of Immunology and Allergy, University of Nantes - INSERM, University of Paris-Saclay - Center for Immunology of Viral, Auto-immune, Hematological and Bacterial Diseases (IMVA-HB/IDMIT), Henri-Mondor/Albert-Chenevier Hospital - Vaccine Research Institute, University of Paris-Saclay - Center for Immunology of Viral, Auto-immune, Hematological and Bacterial Diseases (IMVA-HB/IDMIT), University of Paris-Saclay - Center for Immunology of Viral, Auto-immune, Hematological and Bacterial Diseases (IMVA-HB/IDMIT), University of Paris-Saclay - Center for Immunology of Viral, Auto-immune, Hematological and Bacterial Diseases (IMVA-HB/IDMIT), University of Paris-Saclay - Center for Immunology of Viral, Auto-immune, Hematological and Bacterial Diseases (IMVA-HB/IDMIT), Université Paris-Saclay - Center for Immunology of Viral, Auto-immune, Hematological and bacterial diseases (IMVA-HB/IDMIT), University of Paris-Saclay - Center for Immunology of Viral, Auto-immune, Hematological and Bacterial Diseases (IMVA-HB/IDMIT), University of Paris-Saclay - Center for Immunology of Viral, Auto-immune, Hematological and Bacterial Diseases (IMVA-HB/IDMIT), University of Lausanne - Service of Immunology and Allergy, University of Bordeaux - SISTM team, UMR 1219, University of Bordeaux - SISTM team, UMR 1219, Henri-Mondor/Albert-Chenevier Hospital - Vaccine Research Institute, Henri-Mondor/Albert-Chenevier Hospital - Vaccine Research Institute, University of Paris-Saclay - Center for Immunology of Viral, Auto-immune, Hematological and Bacterial Diseases (IMVA-HB/IDMIT) and University of Claude Bernard Lyon 1 - Inserm
Downloads 73 (867,774)

Abstract:

Loading...

Preclinical study, Immunogenicity, SARS-CoV-2 vaccine candidate, Non-Human Primate, dendritic cell targeting vaccine, CD40

4.

Defining Optimal Vaccine Features for Pandemic Preparedness: An Individual-Based Model Bridging Within- and Between-Host Dynamics

Number of pages: 24 Posted: 07 Apr 2025
McGill University - Epidemiology, Biostatistics, & Occupational Health, University of Bordeaux - ISPED, INSERM U1219, Inria BSO, University of Bordeaux - SISTM team, UMR 1219, McGill University - Epidemiology, Biostatistics, & Occupational Health and University of Bordeaux - SISTM team, UMR 1219
Downloads 67 (924,743)

Abstract:

Loading...

Disease X, Severe acute respiratory syndrome (SARS), Coronavirus, 100 Day mission, Vaccine, mathematical modelling.

5.

Multimodal Integration of Transcriptomics, Proteomics and Radiomics Improves Prediction of Recurrence in Patients with IDH-Mutant Glioma

Number of pages: 54 Posted: 24 Mar 2023
University of Bordeaux - INSERM U1312 BRIC, University of Bordeaux - Inria Monc, IMB, UMR 5251, University of Bordeaux - SISTM team, UMR 1219, Luxembourg Institute of Health (LIH), University of Bordeaux - SISTM team, UMR 1219, University of Milan - Neurosurgical Oncology Unit, University of Bordeaux - INSERM U1312 BRIC, University of Bordeaux - Inria Monc, IMB, UMR 5251, Sorbonne University - Laboratoire de Biologie Computationnelle et Quantitative (LCQB), UMR 7238 CNRS, University of Milan - Department of Oncology and Hemato‐Oncology (DIPO), IRCCS Humanitas Research Hospital - Nuclear Medicine Unit, IRCCS Humanitas Research Hospital - Pathology Unit, Luxembourg Institute of Health (LIH) - Department of Infection and Immunity, University of Bergen - Department of Biomedicine, University of Bordeaux - ISPED, INSERM U1219, Inria BSO, University of Bordeaux - SISTM team, UMR 1219, University of Bordeaux - Inria Monc, IMB, UMR 5251, University of Milan - Neurosurgical Oncology Unit and University of Bordeaux - INSERM U1312 BRIC
Downloads 43 (1,157,785)

Abstract:

Loading...

IDH-mutant glioma, machine learning, prediction, radiomics, recurrence, Signature